Atengenal

DRUG3 trials

Sponsors

Burzynski Research Institute

Conditions

Brain Stem GliomaMixed Gliomas

Phase 2

Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Mixed Gliomas

CompletedNCT00003473

Burzynski Research InstituteMixed Gliomas

Start: 1996-03-31End: 2007-08-31Updated: 2018-01-17

Phase 3

Effect of Antineoplaston Therapy on the QT/QTc Interval In Subjects With Diffuse, Intrinsic, Brainstem Glioma

Not yet recruitingNCT02864888

Burzynski Research InstituteBrain Stem Glioma

Start: 2027-06-30End: 2029-12-31Target: 30Updated: 2025-09-19

Study of Antineoplaston Therapy + Radiation vs. Radiation Only in Diffuse, Intrinsic, Brainstem Glioma

Not yet recruitingNCT02887040

Burzynski Research InstituteBrain Stem Glioma

Start: 2025-10-01End: 2026-06-30Target: 92Updated: 2025-09-16